Precure LLC has picked Helix to handle clinical whole genome and multiomics data from a million biospecimens. This marks a major step for precision medicine at Mayo Clinic and could reshape care across health systems.
City of Hope's PANXEON liquid biopsy shows 87 percent sensitivity for early pancreatic cancer. Now, tough regulatory and reimbursement questions could decide if it ever reaches patients.
Researchers at Sidra Medicine have created a genomic method that combines genetic and brain imaging data to improve early prediction of cognitive decline, paving the way for more tailored brain health strategies.
Andrew Dauber, chief of Endocrinology at Children’s National, received the ESPE International Research Award in Marseille for his work on genetic growth disorders and precision medicine.
